help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 3, 2008
Molecular Endocrinology, doi:10.1210/me.2007-0567
Molecular Endocrinology Vol. 0, No. 2008 200705671-
doi:10.1210/me.2007-0567
Copyright © 2008 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
22/7/1647    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lavoie, P.-L.
Right arrow Articles by Drouin, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lavoie, P.-L.
Right arrow Articles by Drouin, J.

Submitted on December 19, 2007
Accepted on March 25, 2008

Developmental Dependence on NurRE and EboxNeuro for Expression of Pituitary POMC

Pierre-Luc Lavoie, Lionel Budry, Aurélio Balsalobre*, and Jacques Drouin*

Laboratoire de génétique moléculaire, Institut de recherches cliniques de Montréal (IRCM), Montréal QC H2W 1R7 Canada

* To whom correspondence should be addressed. E-mail: aurelio.balsalobre{at}ircm.qc.ca or jacques.drouin{at}ircm.qc.ca.

Cell-specific expression of the pituitary pro-opiomelanocortin (POMC) gene depends on the combinatorial action of a large number of DNA binding transcription factors. These include general and cell-restricted factors, as well as factors that act as effectors of signaling pathways. We have previously defined in the distal POMC promoter a composite regulatory element that contains targets for bHLH transcription factors conferring cell specificity and for NGFI-B orphan nuclear receptors that are responsive to CRH signaling and to glucocorticoid negative feedback. These factors act on neighboring regulatory elements, the EboxNeuro and NurRE, respectively. Currently, the EboxNeuro is thought to be the target of NeuroD1 during fetal development but this factor may not account for activity in the adult pituitary; it is also unknown whether the NurRE and NGFI-B-related factors are active before establishment of the hypothalamic-pituitary portal system. In order to assess the importance of these regulatory elements and their cognate transcription factors throughout pituitary organogenesis and in adult, we have assessed the activity of mutant POMC promoters in transgenic mice throughout development. These experiments indicate that the EboxNeuro and cognate bHLH factors are required throughout development and in the adult gland, beyond expression of NeuroD1. Similarly, the data reveal sustained importance of the NurRE and its cognate factors throughout pituitary development. These data contrast the sustained dependence throughout development on the same regulatory elements with the highly dynamic patterns of transcription factor expression and the modulation of their activity in response to signaling pathways.


Key words: Development • Transcription • NGFI-B • NeuroD1 • ACTH • Transgenics

NURSA Molecule Pages Link:

Nuclear Receptors:   NGFIB  |  NURR1  |  NOR1






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society